Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Niello, M, Cintulova, D, Hellsberg, E, Jäntsch, K, Holy, M, Ayatollahi, LH, Cozzi, NV, Freissmuth, M, Sandtner, W, Ecker, GF, Mihovilovic, MD & Sitte, HH 2019, 'para-Trifluoromethyl-methcathinone is an allosteric modulator of the serotonin transporter', Neuropharmacology, vol. 161, 107615. https://doi.org/10.1016/j.neuropharm.2019.04.021

Activities

Showing entries 1 - 5 out of 202

In silica prediction of toxicity - from QSAR models to biological fingerprinting

Gerhard Ecker
AAPR 23 - patterns in one health
Conference, Talk or oral contribution
25.10.2023 - 25.10.2023

Predicting chemicals' Molecular Initiating Events (MIEs) based on protein structure

Gerhard Ecker
ASPIS Open Symposium
Conference, Talk or oral contribution
25.11.2022 - 25.11.2022

Structure-based prediction of molecular initiating events - where are we?

Gerhard Ecker
3rd In silico Toxicology Conference 2022
Conference, Talk or oral contribution
29.9.2022 - 29.9.2022

Transporter Informatics and Computational Toxicology - from QSAR to Machine Learning and beyond

Gerhard Ecker
Advanced summer School in Drug Research and Development
Summer/Winter school, Talk or oral contribution
7.9.2022 - 7.9.2022

Hypothesis generation for variant effects using a KNIME workflow for ​ automatic mapping of disease-related mutations onto 3D protein structures​

Jiahui Huang , Claire Colas , Gerhard Ecker
ACS Fall 2022
Conference, Poster presentation
21.8.2022 - 21.8.2022